Page last updated: 2024-11-03

propranolol and CKD-MBD

propranolol has been researched along with CKD-MBD in 8 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups."5.26Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. ( Ballanti, P; Bonucci, E; Ciccarelli, C; Maggiore, Q; Pizzarelli, F; Zoccali, C, 1982)
"The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups."1.26Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. ( Ballanti, P; Bonucci, E; Ciccarelli, C; Maggiore, Q; Pizzarelli, F; Zoccali, C, 1982)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pérez-García, R1
Jofre, R1
Vasconez, F1
Caballero, A1
Valderrábano, F1
Pizzarelli, F1
Zoccali, C1
Ciccarelli, C1
Maggiore, Q1
Bonucci, E1
Ballanti, P1
Besarab, A2
Caro, JF2
Ihle, BU1
Burke, JF2
Glennon, JA2
Fischer, JA1
Schaefer, K1
Brancaccio, D2
Galmozzi, C2
Casati, S2
Ponticelli, C2
Eastwood, JB1
Rurale, D1
Belloli, S1
Aroldi, A1
Graziani, G1

Trials

2 trials available for propranolol and CKD-MBD

ArticleYear
[Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency].
    Revista clinica espanola, 1982, Feb-15, Volume: 164, Issue:3

    Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; K

1982
A possible role for propranolol in the treatment of renal osteodystrophy.
    Lancet (London, England), 1978, Aug-26, Volume: 2, Issue:8087

    Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Diso

1978

Other Studies

6 other studies available for propranolol and CKD-MBD

ArticleYear
Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
    Nephron, 1982, Volume: 32, Issue:1

    Topics: Bone Resorption; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Seco

1982
Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.
    Nephron, 1981, Volume: 27, Issue:3

    Topics: Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydrotachysterol;

1981
[Therapy of uremic osteopathy].
    Deutsche medizinische Wochenschrift (1946), 1980, Nov-28, Volume: 105, Issue:48

    Topics: Aluminum Hydroxide; Aluminum Oxide; Calcitonin; Chronic Kidney Disease-Mineral and Bone Disorder; Ci

1980
Propranolol in uraemic osteodystrophy.
    Lancet (London, England), 1978, Oct-28, Volume: 2, Issue:8096

    Topics: Alkaline Phosphatase; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Parathyroid Hormone;

1978
Propranolol in uraemic osteodystrophy.
    Lancet (London, England), 1979, Feb-17, Volume: 1, Issue:8112

    Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Propranolo

1979
Propranolol and uraemic osteodystrophy.
    Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association, 1979, Volume: 16

    Topics: Alkaline Phosphatase; Calcitonin; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hydroxyp

1979